Cargando…
Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts
Somatic mutations in RAS and related pathway genes such as NF1 have been strongly implicated in the development of cancer while also being implicated in a diverse group of developmental disorders named the ‘RASopathies’, including neurofibromatosis type 1 (NF1), Noonan syndrome (NS), Noonan syndrome...
Autores principales: | Dunnett-Kane, V., Burkitt-Wright, E., Blackhall, F.H., Malliri, A., Evans, D.G., Lindsay, C.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322396/ https://www.ncbi.nlm.nih.gov/pubmed/32240795 http://dx.doi.org/10.1016/j.annonc.2020.03.291 |
Ejemplares similares
-
Mechanisms of Resistance to KRAS(G12C) Inhibitors
por: Dunnett-Kane, Victoria, et al.
Publicado: (2021) -
Direct Ras G12C inhibitors: crossing the rubicon
por: Lindsay, Colin R., et al.
Publicado: (2019) -
Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas
por: Chan, Sock Hoai, et al.
Publicado: (2017) -
Parallel imaging of Drosophila embryos for quantitative analysis of genetic perturbations of the Ras pathway
por: Goyal, Yogesh, et al.
Publicado: (2017) -
Contribution of BRCA1 germline mutation in patients with sporadic breast cancer
por: Malik, Fraz A, et al.
Publicado: (2008)